- Home
- PAYS vs XBIT Comparison
PAYS vs XBIT Comparison
Compare PAYS & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYS
- XBIT
- Stock Information
- Founded
- PAYS 2001
- XBIT 2005
- Country
- PAYS United States
- XBIT United States
- Employees
- PAYS N/A
- XBIT N/A
- Industry
- PAYS Business Services
- XBIT Pharmaceuticals and Biotechnology
- Sector
- PAYS Consumer Discretionary
- XBIT Health Care
- Exchange
- PAYS Nasdaq
- XBIT Nasdaq
- Market Cap
- PAYS 117.7M
- XBIT 105.2M
- IPO Year
- PAYS 1998
- XBIT 2015
- Fundamental
- Price
- PAYS $2.75
- XBIT $2.77
- Analyst Decision
- PAYS Strong Buy
- XBIT
- Analyst Count
- PAYS 4
- XBIT 0
- Target Price
- PAYS $6.56
- XBIT N/A
- AVG Volume (30 Days)
- PAYS 151.1K
- XBIT 60.8K
- Earning Date
- PAYS 05-08-2025
- XBIT 05-20-2025
- Dividend Yield
- PAYS N/A
- XBIT N/A
- EPS Growth
- PAYS N/A
- XBIT N/A
- EPS
- PAYS 0.11
- XBIT N/A
- Revenue
- PAYS $63,792,627.00
- XBIT N/A
- Revenue This Year
- PAYS $21.24
- XBIT N/A
- Revenue Next Year
- PAYS $13.64
- XBIT N/A
- P/E Ratio
- PAYS $25.01
- XBIT N/A
- Revenue Growth
- PAYS 26.77
- XBIT N/A
- 52 Week Low
- PAYS $1.80
- XBIT $2.65
- 52 Week High
- PAYS $5.59
- XBIT $9.45
- Technical
- Relative Strength Index (RSI)
- PAYS 66.58
- XBIT 41.56
- Support Level
- PAYS $2.28
- XBIT $2.71
- Resistance Level
- PAYS $2.53
- XBIT $3.08
- Average True Range (ATR)
- PAYS 0.16
- XBIT 0.22
- MACD
- PAYS 0.05
- XBIT -0.01
- Stochastic Oscillator
- PAYS 87.88
- XBIT 17.91
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.